News Releases

Apr 13, 2021
Axcella Announces AXA1125’s IND Clearance for the Treatment of NASH
Mar 17, 2021
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Mar 10, 2021
Axcella to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021
Mar 03, 2021
Axcella Announces Alison D. Schecter, M.D., as President of R&D
Feb 25, 2021
Axcella Announces Upcoming Presentations at NASH-TAG 2021
Feb 18, 2021
Axcella to Present at Upcoming Investor Conferences
Jan 11, 2021
Axcella Announces IND Clearance for AXA1665, Program Updates and 2021 Milestones
Jan 05, 2021
Axcella Announces Upcoming Presentation at J.P. Morgan Healthcare Conference